Downregulation of carbon monoxide as well as nitric oxide contributes to peripheral chemoreflex hypersensitivity in

Yanfeng Ding1, Yu-Long Li, Harold D Schultz

  • 1Department of Cellular and Integrative Physiology, University of Nebraska Medical Center, Omaha, NE 68198-5850, USA.

Insights

Chronic heart failure (CHF) potentiates peripheral chemoreflex sensitivity due to reduced nitric oxide (NO) and carbon monoxide (CO) in the carotid body (CB). Supplementation with NO and CO attenuated hypoxia-induced nerve activity, suggesting their deficiency contributes to this heightened response in CHF.

Area of Science:

  • Cardiovascular Physiology
  • Neuroscience
  • Biochemistry

Background:

  • Peripheral chemoreflex sensitivity is heightened in chronic heart failure (CHF).
  • Nitric oxide (NO) synthase (NOS) downregulation in the carotid body (CB) is implicated, but the role of carbon monoxide (CO) is unclear.
  • Understanding these pathways is crucial for managing CHF-related autonomic dysfunction.

Purpose of the Study:

  • To investigate the combined roles of NO and CO in modulating renal sympathetic nerve activity (RSNA) during hypoxia in a rabbit model of CHF.
  • To determine if deficiencies in NO and CO contribute to augmented peripheral chemoreflex sensitivity in CHF.

Main Methods:

  • Conscious rabbits with experimentally induced CHF and sham controls were subjected to graded hypoxia.
  • Renal sympathetic nerve activity (RSNA) was measured.
  • The effects of NO donor (SNAP) and CO-releasing molecule ([Ru(CO)3Cl2]2) administration, alone and combined, were assessed.
  • Inhibitors of NOS and heme oxygenase (HO) were used.
  • Immunostaining and Western blot analyzed NOS and HO-2 protein expression in CB tissue.

Main Results:

  • Hypoxia-induced RSNA was significantly enhanced in CHF rabbits compared to sham rabbits.
  • Administration of NO donor (SNAP) and CO-releasing molecule ([Ru(CO)3Cl2]2) individually attenuated RSNA increases in CHF rabbits.
  • Combined SNAP and [Ru(CO)3Cl2]2 administration showed a greater attenuation of RSNA than individual treatments.
  • NOS and HO-2 protein expression was significantly lower in the CBs of CHF rabbits compared to sham rabbits.
  • NOS and HO inhibition augmented hypoxia-induced RSNA in sham rabbits, but not in CHF rabbits.

Conclusions:

  • Deficiencies in both nitric oxide (NO) and carbon monoxide (CO) within the carotid body (CB) contribute to the augmented peripheral chemoreflex sensitivity observed in chronic heart failure (CHF).
  • Restoring NO and CO levels may represent a therapeutic strategy for mitigating exaggerated sympathetic responses in CHF.

Related Concept Videos

Chemical Factors Affecting Respiration Centers01:31

Chemical Factors Affecting Respiration Centers

Chemical factors such as changing CO2, O2, and H+ levels in arterial blood play a critical role in influencing respiration depth and rates. These variations are detected by chemoreceptors—specialized sensors located in two primary body areas. Central chemoreceptors are found throughout the brain stem, including the ventrolateral medulla, while peripheral chemoreceptors are located in the aortic arch and carotid arteries.
CO2 has a potent influence on respiration and is strictly regulated. Under...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Neural Regulation of Blood Pressure01:18

Neural Regulation of Blood Pressure

The neural regulation of blood pressure involves intricate interactions between the autonomic nervous system (ANS) and cardiovascular system, ensuring adequate perfusion of tissues. This regulation primarily occurs through baroreceptor and chemoreceptor reflexes, involving both short-term and long-term mechanisms.
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
Regulation of the Cardiovascular System01:27

Regulation of the Cardiovascular System

The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...